Drug Resistance Tuberculosis Epidemic in India: A Review

Background: The emergence of drug-resistant tuberculosis (DR-TB), a challenging health condition to treat, poses serious problems for public health in India. Unfavorable socioeconomic conditions, limited access to healthcare and insufficient diagnostic tools all increase vulnerability. Comorbidities...

Full description

Bibliographic Details
Main Authors: Pranay Deotale, Nitish Mondal
Format: Article
Language:English
Published: Light House Polyclinic Mangalore 2023-07-01
Series:Online Journal of Health & Allied Sciences
Subjects:
Online Access:https://www.ojhas.org/issue86/2023-2-8.html
_version_ 1797767079028326400
author Pranay Deotale
Nitish Mondal
author_facet Pranay Deotale
Nitish Mondal
author_sort Pranay Deotale
collection DOAJ
description Background: The emergence of drug-resistant tuberculosis (DR-TB), a challenging health condition to treat, poses serious problems for public health in India. Unfavorable socioeconomic conditions, limited access to healthcare and insufficient diagnostic tools all increase vulnerability. Comorbidities also make it more difficult to treat TB and promote the development of DR-TB. Objectives: The primary goal of this review study was to focus particularly on the DR-TB epidemic in India. Our understanding of DR-TB will be expanded as a result of this study, which will also make it easier to develop focused interventions and public health regulations to deal with this problem. Methods: A meticulous systematic literature review was carried out using a wide range of electronic databases from around the world, including reputable sources. Results: The prevalence of DR-TB is rising over time. The main factors contributing to the disease's rising prevalence are genetic changes in Mycobacterium tuberculosis, and the appearance of comorbidities in TB patients. In contrast, these elements impair immunity, increase the likelihood of side effects from treatment, and promote the spread of DR-TB. Conclusion: To address the problems brought on by DR-TB, the TB epidemic necessitates a thorough, multi-sectoral approach. Initiatives for targeted public health education and awareness are essential to lowering the prevalence of DR-TB and improving general health outcomes in India.
first_indexed 2024-03-12T20:34:23Z
format Article
id doaj.art-861697d2cfe743d3bf9aa50b82fd91ad
institution Directory Open Access Journal
issn 0972-5997
language English
last_indexed 2024-03-12T20:34:23Z
publishDate 2023-07-01
publisher Light House Polyclinic Mangalore
record_format Article
series Online Journal of Health & Allied Sciences
spelling doaj.art-861697d2cfe743d3bf9aa50b82fd91ad2023-08-01T14:46:15ZengLight House Polyclinic MangaloreOnline Journal of Health & Allied Sciences0972-59972023-07-01222Drug Resistance Tuberculosis Epidemic in India: A ReviewPranay Deotale0Nitish Mondal1Research Scholar, Department of Anthropology, School of Human Sciences, Sikkim University, Gangtok 737102, Sikkim.Associate Professor, Department of Anthropology, School of Human Sciences, Sikkim University, Gangtok 737102, Sikkim.Background: The emergence of drug-resistant tuberculosis (DR-TB), a challenging health condition to treat, poses serious problems for public health in India. Unfavorable socioeconomic conditions, limited access to healthcare and insufficient diagnostic tools all increase vulnerability. Comorbidities also make it more difficult to treat TB and promote the development of DR-TB. Objectives: The primary goal of this review study was to focus particularly on the DR-TB epidemic in India. Our understanding of DR-TB will be expanded as a result of this study, which will also make it easier to develop focused interventions and public health regulations to deal with this problem. Methods: A meticulous systematic literature review was carried out using a wide range of electronic databases from around the world, including reputable sources. Results: The prevalence of DR-TB is rising over time. The main factors contributing to the disease's rising prevalence are genetic changes in Mycobacterium tuberculosis, and the appearance of comorbidities in TB patients. In contrast, these elements impair immunity, increase the likelihood of side effects from treatment, and promote the spread of DR-TB. Conclusion: To address the problems brought on by DR-TB, the TB epidemic necessitates a thorough, multi-sectoral approach. Initiatives for targeted public health education and awareness are essential to lowering the prevalence of DR-TB and improving general health outcomes in India.https://www.ojhas.org/issue86/2023-2-8.htmldrug-resistant tuberculosisindiacomorbiditiestreatment challengesdiagnosis challenges
spellingShingle Pranay Deotale
Nitish Mondal
Drug Resistance Tuberculosis Epidemic in India: A Review
Online Journal of Health & Allied Sciences
drug-resistant tuberculosis
india
comorbidities
treatment challenges
diagnosis challenges
title Drug Resistance Tuberculosis Epidemic in India: A Review
title_full Drug Resistance Tuberculosis Epidemic in India: A Review
title_fullStr Drug Resistance Tuberculosis Epidemic in India: A Review
title_full_unstemmed Drug Resistance Tuberculosis Epidemic in India: A Review
title_short Drug Resistance Tuberculosis Epidemic in India: A Review
title_sort drug resistance tuberculosis epidemic in india a review
topic drug-resistant tuberculosis
india
comorbidities
treatment challenges
diagnosis challenges
url https://www.ojhas.org/issue86/2023-2-8.html
work_keys_str_mv AT pranaydeotale drugresistancetuberculosisepidemicinindiaareview
AT nitishmondal drugresistancetuberculosisepidemicinindiaareview